Skip navigation

A study looking at the genetics of pituitary gland tumours

This study is trying to find genes that may be important in the development of tumours in the pituitary gland. Most pituitary tumours are adenomas.

Very rarely, several members of the same family have a pituitary gland tumour. We know from research that there can be a gene that is abnormal in some of these families. Researchers want to study this and other genes to understand more about how these tumours develop.

In this study, they will take blood samples from people who have a pituitary gland tumour, and from other family members.

The aim of the study is to identify genes that play a part in the development of pituitary gland tumours.

Please note - you won’t get any direct benefit from taking part in this study, nor will it affect any treatment you have. But may it help people in the future.

Recruitment

Start 01/02/2007
End 31/01/2017

Phase

Other

Who can enter

You can enter this trial if you have been diagnosed with a pituitary gland tumour and a member of your family also has (or has had) a pituitary gland tumour. If you are diagnosed before the age of 20, you may be asked to join the trial even if you don't have a relative who has had one of these tumours.

Trial design

The trial team will take a blood sample from everybody taking part in the study. They will use this to study your genes.

If you have surgery to remove a pituitary gland tumour, the researchers will also look at a sample of the tumour.

Hospital visits

Taking part in this study does not involve any extra hospital visits, apart from having the blood test.

Side effects

You may have some discomfort or bruising in the area where the blood sample is taken. There are no other side effects associated with taking part in this study.

Location of trial

For more information

The Information Nurses
Cancer Research UK
Angel Building
407 St John Street
London
EC1V 4AD

Tel: 0808 800 4040
Email: cancer.info@cancer.org.uk

Please note: we cannot help you to join a specific trial. Unless we state otherwise in this trial summary, you must go through your own doctor.

Chief Investigator

Marta Korbonits

Supported by

Barts Health NHS Trust
Barts and The London School of Medicine
National Institute for Health Research (NIHR)